Table 1. Summary of source animals with tonsil biopsies evaluated by sPMCA.
IV, Intravenous; IP, intraperitoneal; IC, intracranial; PO, per os; WBCs, white blood cells; NPD, no prion detected; (+) inoculum source from CWD-positive donor; (−) inoculum source from CWD-negative donor.
| Animal ID | PrP genotype (position 96) | Inoculum | Exposure route | Initial IHC+ tonsil biopsy (months) | Observation period (months) | Obex IHC results at necropsy |
| 104 | G/S | (+) Brain | PO | 12 | 19 | Positive |
| 135 | G/S | (+) Brain | IC | 17 | 17 | Positive |
| 138 | G/G | (+) Brain | IC | 6 | 23 | Positive |
| 148 | G/G | (+) Brain | IC | 12 | 19 | Positive |
| 103 | G/G | (−) Brain | PO/IC | NPD | 19 | NPD |
| 123 | G/G | (−) Brain | PO/IC | NPD | 19 | NPD |
| 4488 | G/S | (−) Brain | PO/IC | NPD | 19 | NPD |
| 4516 | G/G | (−) Brain | PO/IC | NPD | 19 | NPD |
| 114 | G/G | (+) Blood | IP | 19 | 19 | Positive |
| 133 | G/G | (+) Blood | IV | 12 | 26 | Positive |
| 137 | G/S | (+) Blood | IV | 19 | 19 | Positive |
| 302 | G/S | (+) Blood | IV | 12 | 27 | Positive |
| 347 | G/S | (+) Blood | IV | 6 | 27 | Positive |
| 372 | G/G | (+) Blood | IV | 12 | 26 | Positive |
| 374 | G/G | (+) Blood | IV | 6 | 24 | Positive |
| 4116 | G/G | (+) Blood | IV | 12 | 19 | Positive |
| 4119 | G/S | (+) Blood | IV | 12 | 24 | Positive |
| 4502 | G/G | (+) Blood | IV | 6 | 24 | Positive |
| 4513 | G/G | (+) Blood | IV | 6 | 19 | Positive |
| 4128 | G/G | (+) WBCs | IV | 12 | 19 | Positive |
| 4506 | G/S | (+) WBCs | IV | 19 | 19 | Positive |
| 4512 | G/G | (+) WBCs | IV | 15 | 18 | Positive |
| 4521 | G/S | (+) WBCs | IV | 19 | 19 | Positive |
| 307 | G/G | (+) Monocytes | IV | NPD | 19 | NPD |
| 311 | G/S | (+) Monocytes | IV | NPD | 19 | NPD |
| 360 | G/G | (+) Monocytes | IV | NPD | 19 | NPD |
| 373 | G/G | (+) Monocytes | IV | NPD | 19 | NPD |
| 323 | G/S | (+) Platelets | IV | NPD | 19 | NPD |
| 324 | G/G | (+) Platelets | IV | 19 | 19 | Positive |
| 325 | G/G | (+) Platelets | IV | 12 | 19 | Positive |
| 357 | G/G | (+) Platelets | IV | 19 | 19 | Positive |
| 4117 | G/G | (+) Plasma | IV | NPD | 19 | NPD |
| 4410 | G/S | (+) Plasma | IV | NPD | 19 | NPD |
| 4515 | G/G | (+) Plasma | IV | NPD | 19 | NPD |
| 303 | G/S | (+) B-cells | IV | 12 | 19 | Positive |
| 322 | G/G | (+) B-cells | IV | 19 | 19 | Positive |
| 346 | G/G | (+) B-cells | IV | 12 | 19 | Positive |
| 371 | G/G | (+) B-cells | IV | 19 | 19 | Positive |
| 113 | G/G | (+) Saliva | PO | 12 | 19 | Positive |
| 132 | G/G | (+) Saliva | PO | 19 | 19 | Positive |
| 147 | G/G | (+) Saliva | PO | NPD | 19 | NPD |
| 111 | G/S | (+) Urine/faeces | PO | NPD | 27 | NPD |
| 124 | G/S | (+) Urine/faeces | PO | NPD | 27 | NPD |
| 134 | G/G | (+) Urine/faeces | PO | NPD | 27 | NPD |
| 141 | G/G | (+) Urine/faeces | PO | NPD | 27 | NPD |
| 150 | G/G | (+) Urine/faeces | PO | NPD | 27 | NPD |
| 4129 | G/S | (+) Environment | Unknown | 19 | 19 | Positive |
| 4461 | G/S | (+) Environment | Unknown | 19 | 19 | Positive |